Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage (Q28577418)

31 January 2017

title

Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage (English)

1 reference

31 January 2017

1 reference

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

author name string

G. Gao

1

1 reference

31 January 2017

C. Shao

2

1 reference

31 January 2017

S. X. Zhang

3

1 reference

31 January 2017

A. Dudley

4

1 reference

31 January 2017

J. Fant

5

1 reference

31 January 2017

J-X Ma

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743698

1 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743698

1 January 2024

publication date

1 May 2003

1 reference

31 January 2017

13 May 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743698

full work available at URL

1 January 2024

https://link.springer.com/content/pdf/10.1007/s00125-003-1085-9.pdf

file format

Portable Document Format

online access status

open access

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743698

http://link.springer.com/content/pdf/10.1007/s00125-003-1085-9.pdf

1 January 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

http://link.springer.com/article/10.1007/s00125-003-1085-9/fulltext.html

1 January 2024

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

http://link.springer.com/content/pdf/10.1007/s00125-003-1085-9

1 January 2024

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

1 reference

31 January 2017

volume

46

1 reference

31 January 2017

issue

5

1 reference

31 January 2017

page(s)

689–698

1 reference

Identification of RPE65 in transformed kidney cells

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop

21 April 2017

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature

21 April 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Mechanistic insights on the inhibition of tumor angiogenesis.

21 April 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Molecular mechanisms of blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

[Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Targeting kinin B(1) receptor for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Identification of a new tissue-kallikrein-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Kallistatin is a new inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Tissue kallikrein-binding protein reduces blood pressure in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Interaction of endostatin with integrins implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

Expression and characterization of rat kallikrein-binding protein in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-003-1085-9

The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules

21 January 2018

1 reference

12 December 2020

Regulation of cell growth by vitreous humour.

1 reference

12 December 2020

Tissue kallikrein-binding protein is a serpin. I. Purification, characterization, and distribution in normotensive and spontaneously hypertensive rats

1 reference

12 December 2020

Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.

1 reference

12 December 2020

Oxygen-induced retinopathy in the mouse

1 reference

12 December 2020

Molecular cloning and analysis of the rat kallikrein-binding protein gene

1 reference

12 December 2020

Distribution of albumin in the normal monkey eye as revealed by Evans blue fluorescence microscopy.

1 reference

12 December 2020

Growth hormone induces two mRNA species of the serine protease inhibitor gene family in rat liver

1 reference

12 December 2020

Bioregulation of kinins: kallikreins, kininogens, and kininases

1 reference

12 December 2020

Vitreous: an inhibitor of retinal extract-induced neovascularization

1 reference

12 December 2020

Inhibition of neovascularization by an extract derived from vitreous

1 reference

12 December 2020

Kallikrein-binding protein is induced by growth hormone in the dwarf rat

1 reference

12 December 2020

Vascular endothelial growth factor and ocular neovascularization.

1 reference

12 December 2020

Maspin is an angiogenesis inhibitor

1 reference

12 December 2020

Culture of retinal capillary cells using selective growth media

1 reference

12 December 2020

Plasminogen activator production by human retinal endothelial cells of nondiabetic and diabetic origin

1 reference

12 December 2020

Isolation and identification of stimulatory and inhibitory cell growth factors in bovine vitreous

1 reference

12 December 2020

Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence

1 reference

12 December 2020

Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow.

1 reference

12 December 2020

Diabetic retinopathy: a review.

1 reference

12 December 2020

Sensitive blood-retinal barrier breakdown quantitation using Evans blue

1 reference

12 December 2020

Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats

1 reference

12 December 2020

Kallikreins and kinins, an overview: some thoughts old and new

1 reference

12 December 2020

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

1 reference

12 December 2020

Vascular endothelial cell growth inhibitor of normal and pathologic human vitreous

1 reference

12 December 2020

Interaction of endostatin with integrins implicated in angiogenesis

1 reference

12 December 2020

8

24

52

Lutty

1983

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

Pharmacological Reviews

15

44

1

Bhoola

1992

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

23

38

658

Hatcher

1997

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

33

32

53

Grant

1991

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

38

35

101

Smith

1994

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

39

42

789

Xu

2001

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9

1 January 2024

40

19

238

Radius

1980

1 reference

https://api.crossref.org/works/10.1007/S00125-003-1085-9